MRI with special contrast to study brain and other CNS problems
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether two special MRI contrast medicines—gadolinium and ferumoxytol—can better diagnose problems in the brain or central nervous system. It may help doctors identify what’s causing symptoms or abnormal brain findings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptoms that could be from the brain or central nervous system, OR an abnormal brain scan, OR cancer outside the brain that could affect the brain
- You can have an MRI without needing anesthesia (you can stay still with normal help, if needed)
- You are age 10 or older (or you’re the legal guardian of a child in this age range)
- You (or your guardian) can sign consent and allow use of your health information
- If you can become pregnant, you agree to use effective birth control during the study and for 2 months after each study cycle
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new kind of PET scan that uses a special tracer (Zr-89 crefmirlimab berdoxam) to help doctors see brain tumors more clearly before surgery. If you are scheduled to have your brain tumor removed, this scan may give your surgeon extra information to guide the operation.
This trial studies whether a brain PET scan using a medicine called FMISO can help show how active certain brain tumors are. It mainly aims to see if the scan is practical and useful in planning care for people with suspected or known brain tumors.
This trial uses a new type of MRI contrast dye (USPIO) to get clearer images of certain slow-growing brain tumors (vestibular schwannomas and low-grade gliomas). The goal is to see if this dye helps doctors better understand and treat these tumors.
This trial uses special MRI scans and a contrast agent to look at the immune environment of glioblastoma tumors. It may help doctors learn more about how the tumor responds to treatment.
This study tests a new MRI sequence to see if it can better detect brain metastases. You may be eligible if you are scheduled for a brain MRI with contrast and have known or suspected brain metastases.
This trial uses a special MRI scan that shows how “metabolism” (how cells use fuel) differs in brain tumors. It may help researchers better understand tumor biology and how tumors may respond to treatment, without using chemotherapy or radiation as part of the study.
Hear when a new Cranial Nerve Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.